The market for antibody production is projected to reach USD 37.81 Billion by 2030, with a compound annual growth rate (CAGR) of 14.4% during the forecast period. Factors such as the rising prevalence of infectious and bacterial diseases, increased investments to expedite the development of innovative antibiotic therapies, and a growing number of research and development (R&D)...